---
title: "CERo Therapeutics Announces Clinical Update from CERTAIN-T Phase 1 CER-1236 Trial, Including Patient Undergoing Allogeneic Stem Cell Transplant Following Treatment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289784441.md"
description: "The fifth individual administered with CER-1236, who did not show improvement with previous treatments, received a stem cell transplant. The company has commenced the third intended group in the continuous Phase 1 trial for hematologic malignancies."
datetime: "2026-06-15T12:16:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289784441.md)
  - [en](https://longbridge.com/en/news/289784441.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289784441.md)
---

# CERo Therapeutics Announces Clinical Update from CERTAIN-T Phase 1 CER-1236 Trial, Including Patient Undergoing Allogeneic Stem Cell Transplant Following Treatment

The fifth individual administered with CER-1236, who did not show improvement with previous treatments, received a stem cell transplant. The company has commenced the third intended group in the continuous Phase 1 trial for hematologic malignancies.

### Related Stocks

- [CERO.US](https://longbridge.com/en/quote/CERO.US.md)
- [CEROW.US](https://longbridge.com/en/quote/CEROW.US.md)

## Related News & Research

- [Neurogene publishes corporate presentation highlighting NGN-401 gene therapy program for Rett syndrome](https://longbridge.com/en/news/295530994.md)
- [International Stem Cell board backs USD 25 million sale of Lifeline Cell Technology to ATCC](https://longbridge.com/en/news/294873976.md)
- [Hong Kongs First PIC/S GMP-Certified Stem Cell Production Facility Established at Science Park](https://longbridge.com/en/news/294784103.md)
- [Corvus publishes corporate presentation highlighting soquelitinib ITK inhibitor pipeline in immune disease and T-cell malignancies](https://longbridge.com/en/news/295155153.md)
- [Nvidia’s Best Customers Have a Reason to Stop Buying So Many Nvidia Chips](https://longbridge.com/en/news/295572288.md)